The invention relates to modulators of
proteolysis and related methods of use. The present disclosure relates to
bifunctional compounds that are useful as modulators of Kirsteen rat
sarcoma proteins (target proteins). In particular, the present disclosure relates to
bifunctional compounds having one end containing a Von Hippel-Lindau, cerebron, an apoptotic
protein inhibitor or a mouse double minute 2 homolog ligand that binds to the respective E3
ubiquitin ligase and the other end containing a
moiety that binds to a
target protein such that the
target protein is placed in proximity to the
ubiquitin ligase to effect degradation (and inhibition) of the
target protein. The present disclosure exhibits a broad range of pharmacological activities related to degradation / inhibition of a target
protein. Treatment or prevention of diseases or conditions caused by aggregation, accumulation and / or overactivity of target proteins with the compounds and compositions of the invention.